Skip to main content
RRX $175.49 +2.88%
RRX logo

RRX · Regal Rexnord Corp

Track RRX — free
$175.49 +4.91 (+2.88%) At close · Aug 14
Market Cap
$11.69B
Shares
66.59M
All earnings calls

Earnings call · FY2024 Q3

Regal Rexnord Corp Q3 FY2024 Earnings Call

Regal Rexnord Corp Q3 FY2024 Earnings Call

Concluded Nov 5, 2024
Nov 5, 2024 67 turns
Period
FY2024 Q3
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Powertrain strategy and aftermarket 46 Organic sales decline and weak end markets 25 Synergy capture from acquisitions 24 Margin expansion and record profitability 21 Residential HVAC ramp and capacity constraints 21 2025 outlook and guidance 12

Management tone

Positive

Net tone +25 · moderate hedging

Grounding quotes
  • “a record adjusted gross margin of 38.4% and a record adjusted EBITDA margin of 22.8%, which is up 110 basis points versus prior year on a comparable basis”
  • “we were disappointed in our overall third quarter sales results with sales down 2.7% on a comparable organic basis, driven mainly by our AMC and PES segments facing end-market headwinds that continued to be more severe than we expected”
  • “we expect this to be largely resolved during fourth quarter”
  • “weighted to longer-cycle bookings helps give us confidence that we will see better top-line performance in 2025”

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $1.48B -10.4% YoY
Diluted EPS $1.09
Gross margin 37.7% +4.8 pp YoY
Net income $72.70M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · regions

North America$1.04B -8.3% YoY
Europe$241.40M -11.7% YoY
Asia$103.80M -30.4% YoY
Rest of World$92.80M -1.1% YoY

Capital returned

Dividend / share
$0.35
Full-screen source Call document